Senzime to conduct clinical trial at University of Debrecen, Hungary
Uppsala, November 15, 2016: Senzime (publ) launches a clinical study at the University of Debrecen, Hungary. This study will evaluate Senzime’s patient neuromonitoring system called TetraGraph, used during anesthesia. This study is designed to investigate the clinical utility of the system in a total of 40 patients, and will compare its ease of use, reliability and precision to the former leading product, the TOF-Watch, that has been discontinued from the market. Results are scheduled for presentation as early as the first quarter of 2017.Every year over 70 million surgical patients undergo